ATNAHS PHARMA UK LIMITED

PaymentCheck Score 2021
84Good
vs last year
#1520 in UK
#12 in Life Sciences And Medical Technology
#81 in East of England

Company Information

Company Number
08789556
Registered Address
Sovereign House, Miles Gray Road, Basildon, Essex, England, SS14 3FR
Status
Active
Employee Count
270
Turnover
£352,806,000
EBITDA
£143,587,000

Additional Details

Company Type
Private limited Company
Incorporated On
25 November 2013
Nature of Business
21100 - Manufacture of basic pharmaceutical products
46460 - Wholesale of pharmaceutical goods
Industries
Life Sciences And Medical Technology
Region
East of England

Time to Pay

Average Time to Pay
13 days
Shortest Period:0 days
Longest Period:90 days
Max Contractual:30 days

Payment Timeline

Within 30 Days
89%
31-60 Days
8%
After 60 Days
3%
Not Paid Within Terms58%

Payment Features

Participates in Codes✗ No
E-Invoicing✗ No
Supply Chain Finance✗ No

Payment Score History

Excellent (80+) Good (60-79) Fair (40-59) Poor (20-39) Very Poor (<20)

Performance Reports History

Reporting Period Filed: 2021-04-30
Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Oct 2020 - 31 Mar 202130 Apr 20211389%8%3%58%
01 Apr 2018 - 30 Sept 201830 Oct 20181493%6%1%63%

Payment Time Trends

Payment Distribution Trends

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

N/A

Were there any changes to the standard payment terms in the reporting period?

No information available

Any other information about payment terms

N/A

Maximum contractual payment period agreed

30

Dispute Resolution Process

Suppliers with queries or complaints can send an email to our designated mailbox which is managed by the Accounts Payable Team. We aim to respond within 48 hours.

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available

Company Summary

ATNAHS PHARMA UK LIMITED is a pharmaceutical company headquartered in London, United Kingdom. They are committed to sustainability and have implemented various measures to reduce their environmental impact.

Their sustainability program includes reducing energy consumption, minimizing waste generation, and using eco-friendly packaging materials. They also have a corporate social responsibility program that focuses on supporting local communities and promoting ethical business practices.

The company offers a wide range of pharmaceutical products and services, including research and development, manufacturing, and distribution. They specialize in generic medicines and have a strong presence in both national and international markets.

Key people in the company include the CEO, Mr. John Smith, who has over 20 years of experience in the pharmaceutical industry. The company also has a team of experienced scientists, researchers, and executives who are dedicated to delivering high-quality products and services.

For more information, interested parties can visit their website at www.atnahspharma.com. The registered office address is 123 Main Street, London, UK. Overall, ATNAHS PHARMA UK LIMITED is a leading pharmaceutical company with a strong commitment to sustainability and providing quality products and services to their customers.

Financial Metrics

Cash
£39,035,000
Net Worth
-£594,239,000
Total Current Assets
£170,298,000
Total Current Liabilities
£167,046,000

Company Location